Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | TGM2 | P21980 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.55 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.52 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | IDO1 | P14902 | 1/20 | 0.49 |
| ▸ | TDO2 | P48775 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionaldehyde SCHEMBL3691420 | 0.92 | LMNA (0.57) | LMNASMN1; SMN2HTTTGM2L3MBTL1 | |
| SCHEMBL30869144 | 0.92 | HTT (0.58) | LMNASMN1; SMN2HTTTGM2L3MBTL1 | |
| SCHEMBL735886 | 0.91 | HTT (0.68) | LMNASMN1; SMN2HTTTGM2L3MBTL1 | |
| SCHEMBL23120177 | 0.90 | L3MBTL1 (0.62) | LMNASMN1; SMN2HTTTGM2L3MBTL1 | |
| SCHEMBL13055383 | 0.90 | LMNA (0.80) | LMNASMN1; SMN2HTTTGM2L3MBTL1 | |
| SCHEMBL3725943 | 0.89 | HTT (0.67) | LMNASMN1; SMN2HTTTGM2L3MBTL1 | |
| SCHEMBL7407279 | 0.89 | LMNA (0.65) | LMNASMN1; SMN2HTTTGM2L3MBTL1 | |
| SCHEMBL5019074 | 0.88 | LMNA (0.73) | LMNASMN1; SMN2HTTTGM2L3MBTL1 | |
| SCHEMBL8988858 | 0.88 | TGM2 (0.69) | LMNASMN1; SMN2HTTTGM2L3MBTL1 | |
| SCHEMBL8811162 | 0.88 | TGM2 (0.69) | LMNASMN1; SMN2HTTTGM2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 388 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200165640-A1 | FRUCTOSE-6-PHOSPHATE ALDOLASE VARIANTS FOR ALDOL CARBOLIGATIONS | SUSTAINABLE MOMENTUM, S.L. (ES) | 2020-05-28 | — | — | US | claimed |
| CN-110945122-A | Fructose-6-phosphate aldolase variants for aldol condensation carbon linking | 西班牙高等科研理事会 | 2020-03-31 | — | — | CN | claimed |
| EP-3610011-A1 | FRUCTOSE-6-PHOSPHATE ALDOLASE VARIANTS FOR ALDOL CARBOLIGATIONS | Consejo Superior de Investigaciones Cientificas (CSIC) (ES) | 2020-02-19 | — | — | EP | claimed |
| WO-2018189026-A1 | FRUCTOSE-6-PHOSPHATE ALDOLASE VARIANTS FOR ALDOL CARBOLIGATIONS | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2018-10-18 | — | — | WO | claimed |
| EP-3388518-A1 | FRUCTOSE-6-PHOSPHATE ALDOLASE VARIANTS FOR ALDOL CARBOLIGATIONS | Consejo Superior de Investigaciones Cientificas (CSIC) (ES) | 2018-10-17 | — | — | EP | claimed |
| US-8288132-B2 | Chemoenzymatic process for the preparation of iminocyclitols | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2012-10-16 | — | — | US | claimed |
| EP-2185713-A2 | PROCESS FOR PREPARING CHIRAL COMPOUNDS | Pfizer Products Inc. (US) | 2010-05-19 | — | — | EP | claimed |
| EP-2061892-B1 | CHEMOENZYMATIC PROCESS FOR THE PREPARATION OF IMINOCYCLITOLS | CONSEJO SUPERIOR INVESTIGACION (ES) | 2010-02-03 | — | — | EP | claimed |
| US-20100009417-A1 | Chemoenzymatic process for the preparation of iminocyclitols | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (ES) | 2010-01-14 | — | — | US | claimed |
| EP-2061892-A1 | CHEMOENZYMATIC PROCESS FOR THE PREPARATION OF IMINOCYCLITOLS | Consejo Superior de Investigaciones Cientificas (CSIC) (ES) | 2009-05-27 | — | — | EP | claimed |
| WO-2009019561-A2 | PROCESS FOR PREPARING CHIRAL COMPOUNDS | PFIZER PRODUCTS INC. (US) | 2009-02-12 | — | — | WO | claimed |
| WO-2008025826-A1 | CHEMOENZYMATIC PROCESS FOR THE PREPARATION OF IMINOCYCLITOLS | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (ES) | 2008-03-06 | — | — | WO | claimed |
| EP-1893767-A1 | PROCESS FOR PRODUCING ATORVASTATIN, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND INTERMEDIATES THEREOF | Pfizer, Inc. (US) | 2008-03-05 | — | — | EP | claimed |
| WO-2006134482-A1 | PROCESS FOR PRODUCING ATORVASTATIN, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND INTERMEDIATES THEREOF | PFIZER INC. (US) | 2006-12-21 | — | — | WO | claimed |
| EP-3364967-B1 | FERROPORTIN INHIBITORS | VIFOR INT AG (CH) | 2026-05-20 | — | — | EP | disclosed |
| US-20260124205-A1 | MODULATORS OF BETA CATENIN AND USES THEREOF | DEWPOINT THERAPEUTICS INC (US) | 2026-05-07 | — | — | US | disclosed |
| WO-2026090104-A1 | MODULATORS OF BETA CATENIN AND USES THEREOF | DEWPOINT THERAPEUTICS, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| EP-0297496-A2 | Novel process for the preparation of 6,7-Diacyl-7-deacetylforskolin derivatives | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1989-01-04 | — | — | EP | disclosed |
| US-4795809-A | CLAVULANIC ACID INTERMEDIATE | BEECHAM GROUP PLC (GB) | 1989-01-03 | — | — | US | disclosed |
| EP-0213914-A2 | Clavam derivatives, preparation and intermediates therefor | BEECHAM GROUP PLC (GB) | 1987-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124205-A1 | MODULATORS OF BETA CATENIN AND USES THEREOF | CTNNB1, CTNNA1, CTNND1 | LMNA 275/4885SMN1; SMN2 2898/4885HTT 3044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.